Capital City Bank Group, Inc. (CCBG)

Theseus Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Interest Income on Loans	164.46	164.93	152.25	106.44	96.56	94.75
Interest Income on Investments	35.85	29.72	28.82	25.47	9.79	11.45
Total Interest Income	200.31	194.66	181.07	131.91	106.35	106.2
Interest Paid on Deposits	30.78	32.16	17.58	3.44	0.84	1.55
Interest Paid on Borrowings	3.49	3.56	4.5	3.44	2.65	3.32
Total Interest Expense	34.27	35.72	22.08	6.89	3.49	4.87
Net Interest Income	166.05	158.94	158.99	125.02	102.86	101.33
Net Interest Income Growth (YoY)	6.39%	-0.03%	27.17%	21.55%	1.52%	-1.95%
Trust Income	20.96	19.11	16.34	18.06	13.69	11.04
Mortgage Banking Activities	15.09	14.34	10.4	11.91	52.43	63.34
Gain (Loss) on Sale of Assets	-	-	1.4	-	-	-
Other Non-Interest Income	21.04	21.17	22.15	23.09	22.55	18.99
Total Non-Interest Income	78.19	75.98	71.61	75.18	107.55	111.17
Non-Interest Income Growth (YoY)	9.23%	6.10%	-4.75%	-30.09%	-3.26%	109.54%
Revenues Before Loan Losses	244.24	234.91	230.6	200.2	210.41	212.49
Provision for Loan Losses	3.3	4.03	9.71	7.49	-1.55	9.65
Revenue	240.94	230.88	220.88	192.71	211.96	202.85
Revenue Growth (YoY)	8.96%	4.53%	14.62%	-9.08%	4.49%	31.40%
Salaries and Employee Benefits	101.64	97.92	91.59	89.22	99.87	94.58
Occupancy Expenses	15.03	15.39	14.63	13.39	13.05	12.15
Selling, General & Administrative	18.92	18.5	18.58	16.69	15.16	15.21
Other Non-Interest Expense	30.36	33.5	32.23	32.33	34.42	27.96
Total Non-Interest Expense	165.94	165.32	157.02	151.63	162.51	149.9
EBT Excluding Unusual Items	75	65.57	63.86	41.08	49.45	52.95
Other Unusual Items	-	-	-	-	-	-0.06
Pretax Income	75	65.57	63.86	41.08	49.45	52.88
Income Tax Expense	17.32	13.92	13.04	7.8	9.84	10.23
Earnings From Continuing Operations	57.68	51.64	50.82	33.28	39.62	42.65
Minority Interest in Earnings	0.43	1.27	1.44	0.14	-6.22	-11.08
Net Income	58.11	52.92	52.26	33.41	33.4	31.58
Net Income to Common	58.11	52.92	52.26	33.41	33.4	31.58
Net Income Growth	13.76%	1.26%	56.41%	0.05%	5.76%	2.50%
Basic Shares Outstanding	17	17	17	17	17	17
Diluted Shares Outstanding	17	17	17	17	17	17
Shares Change (YoY)	0.21%	-0.32%	0.22%	0.54%	0.42%	-0.03%
EPS (Basic)	3.42	3.12	3.08	1.97	1.98	1.88
EPS (Diluted)	3.42	3.12	3.07	1.97	1.98	1.88
EPS Growth	14.00%	1.63%	55.84%	-0.51%	5.32%	2.73%
Dividend Per Share	0.940	0.880	0.760	0.660	0.620	0.570
Dividend Growth	14.63%	15.79%	15.15%	6.45%	8.77%	18.75%
Effective Tax Rate	23.09%	21.24%	20.42%	18.98%	19.89%	19.34%

Updated Apr 30, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.

SEC Filings: 10-K · 10-Q